Price controls and compulsory licences lead to double trouble in India
Last week, an Indian panel of ministers proposed that that the government put all 348 drugs on the country’s National List of Essential Medicines under price control, including a number of patented drugs. The structure of the scheme provides incentives to target patented drugs on the list
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
